Addiction and “Medicare for All”

July 18, 2019 by C. Scott McMillin

I’d argue that America has never adequately addressed its own problems with addiction, which have been with us in one form or another since before we became a nation.

Topics:


Myth or Not?

March 19, 2018 by C. Scott McMillin

Too many doctors worry about “those people” showing up in the waiting room. They don’t particularly want to be known as a resource for the addicted.

Topics: , , , ,


When It’s Just Business

November 9, 2017 by C. Scott McMillin

I know how often the quest for business success has in the past overtaken and even overwhelmed the quest to deliver good services.

Topics: , ,


Opioid Alternatives

October 16, 2017 by C. Scott McMillin

The larger issue is that most drug pricing is still market-driven, or as my endocrinologist puts it, “they charge whatever they can get away with charging.”

Topics: , ,


Getting Drugs From Docs Part Two: The Targets

August 31, 2017 by C. Scott McMillin

There are just too many different forms of manipulation for any of us to be uniformly good at identifying them on the fly.

Topics: , , ,


Pain Pill Cycle

April 3, 2017 by C. Scott McMillin

Modern healthcare, for all its spectacular innovation, still lacks a genuinely safe, effective remedy for certain types of pain.

Topics: , ,


In the News: Keeping It Covered

March 20, 2017 by C. Scott McMillin

With the increased risk of overdose from fentanyl and other synthetics, the path to recovery may be even bumpier, in terms of repeat emergencies. The folks in the Business Office would rather avoid that.

Topics:


Stigma Behind the Stethoscope

February 13, 2017 by C. Scott McMillin

There’s no shortage of stories among nurses and doctors about a friend or family member who went through treatment and relapsed, perhaps many times.

Topics: , , ,


In the News: The Human Element

January 30, 2017 by C. Scott McMillin

A doc who’s watching the clock is far less likely to expend valuable time chatting with a patient.

Topics: , ,


In the News: Anatomy of a Scam

January 16, 2017 by C. Scott McMillin

Medicare spending on compounded topical drugs has surged 3400% since 2006.

Topics: ,


Subscribe to RecoverySI via Email

Join 3,593 other subscribers


New Content